Haematology — Chronic Lymphocytic Leukaemia
Cardiovascular implications of chronic lymphocytic leukaemia and its treatment.
Chronic lymphocytic leukaemia is among the most common adult leukaemias, and its targeted therapies have transformed outcomes. At the same time, atrial fibrillation, hypertension and bleeding risk are increasingly recognised alongside treatment. This theme examines practical cardiovascular monitoring and management throughout the CLL care pathway.
- Cardiovascular risk in CLL
- Arrhythmia and bleeding considerations
- Monitoring during targeted therapy
